Article

Modulation of the sensitivity to ruxolitinib-mediated JAK2 inhibition by mutationally activated SHP2 exhibits cell context dependency in pre-clinical models of myeloproliferative neoplasms

2026-08-20

Abstract excerpt

Classic Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) are hematopoietic stem cell cancers that result in aberrant trilineage myeloid cell proliferation, bone marrow fibrosis, and increased risk of acute myeloid leukemia. MPNs are driven by deregulated activity of the JAK2 kinase, induced by mutations in the JAK2, CALR, and MPL genes, but approved JAK2 inhibitors primarily offer palliative ef...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aa2e3a96-5fd2-58ca-a0aa-5038d27dff1e
DOI: 10.64898/2026.08.19.744423

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Modulation of the sensitivity to ruxolitinib-mediated JAK2 inhibition by mutationally activated SHP2 exhibits cell context dependency in pre-clinical models of myeloproliferative neoplasmsDOI 10.64898/2026.08.19.744423Read

Targeting SHP2 phosphatase in hematological malignancies.Semantic proximity Read

SHP-2 and myeloid malignancies.Semantic proximity Read

Genome-wide CRISPR/Cas9 Screens Reveal Shared and Bespoke Mechanisms of Resistance to SHP2 inhibitionSemantic proximity Read

JAK2 inhibition for the treatment of hematologic and solid malignanciesSemantic proximity Read

Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasmsSemantic proximity Read

Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance.Semantic proximity Read

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.Semantic proximity Read

Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD-Driven AML.Semantic proximity Read

Genome editing for treatment of <i>JAK2</i> V617F-driven myeloproliferative neoplasmsSemantic proximity Read

Inhibition of SHP2 as an approach to block RAS-driven cancers.Semantic proximity Read

The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo.Semantic proximity Read

Shp2 function in hematopoietic stem cell biology and leukemogenesisSemantic proximity Read